Epidemiologic evidence of health effects from long-distance transit of chemical weapons fallout from bombing early in the 1991 Persian Gulf War

Neuroepidemiology

Volumn 40, Issue 3, 2013, Pages 178-189

  Haley, Robert W ^a   Tuite, James J ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b International Security and Risk Management Consultant   (United States)

Author keywords

Chemical alarms; Chemical warfare agents; Persian Gulf syndrome; Sarin; Survey

Indexed keywords

ARTICLE; CHEMICAL WARFARE; CHRONIC DISEASE; FALLOUT; HEALTH STATUS; HEALTH SURVEY; HUMAN; POPULATION RESEARCH; TELECONSULTATION; VETERAN; WAR;

ADULT; BOMBS; CHEMICAL WARFARE AGENTS; DATA COLLECTION; FEMALE; GULF WAR; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MILITARY PERSONNEL; PERSIAN GULF SYNDROME; TRANSPORTATION;

EID: 84871228736     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000345124     Document Type: Article

References (48)

1. Research Advisory Committee on Gulf War Veterans' Illnesses: Gulf War Illness and the Health of Gulf War Veterans. 2008. http://www1.va.gov/rac-gwvi/.
2. Haley RW, Charuvastra E, Shell WE, Buhner DM, Marshall WW, Biggs MM, Hopkins S, Wolfe GI, Vernino S: Cholinergic autonomic dysfunction in veterans with Gulf War illness: confirmation in a population-based sample. Arch Neurol 2012 (published online, Nov. 26, 2012).
3. Haley RW, Spence JS, Carmack PS, Gunst RF, Schucany WR, Petty F, Devous MD Sr, Bonte FJ, Trivedi MH: Abnormal brain response to cholinergic challenge in chronic encephalopathy from the 1991 Gulf War. Psychiatry Res 2009; 171: 207-220.
4. Li X, Spence JS, Buhner DM, Hart J Jr, Cullum CM, Biggs MM, Hester AL, Odegard TN, Carmack PS, Briggs RW, Haley RW: Hippocampal dysfunction in Gulf War veterans: investigation with ASL perfusion MR imaging and physostigmine challenge. Radiology 2011; 261: 218-225.
5. Magill AJ, Grogl M, Gasser RA Jr, Sun W, Oster CN: Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993; 328: 1383-1387.
6. US Senate Committee on Banking, Housing and Urban Affairs: US chemical and biological warfare-related dual use exports to Iraq and their possible impact on the health consequences of the Persian Gulf War. 1994. http://www.gulfweb.org/bigdoc/report/riegle1.html.
7. Office of the Special Assistant for Gulf War Illnesses: Case narrative: Czech and French reports of possible chemical agent detections. 7-29-1998. http://www.gulflink.osd.mil/czech-french/.
8. Defense Science Board: Report of the Defense Science Board Task Force on Persian Gulf War Health Effects. 1994. http://www.gulflink.osd.mil/dsbrpt/.
9. National Institutes of Health: The Persian Gulf experience and health: National Institutes of Health technology assessment workshop statement, April 27-29, 1994. http://consensus.nih.gov/1994/1994PersianGulfta0.14PDF.pdf.
10. Tuite JJ, Haley RW: Meteorological and intelligence evidence of long-distance transit of chemical weapons fallout from bombing early in the 1991 Persian Gulf war. Neuroepidemiology 2013; 40: 160-177.
11. US General Accounting Office: Gulf War illnesses: DoD's conclusions about US troops' exposure cannot be adequately supported, report to the Congressional requesters (GAO-04-159 Gulf War Illnesses). 2004. http://www.gao.gov/new.items/ d04159.pdf.
12. Pine A: Count of troops exposed to toxic cloud may triple. Los Angeles Times, Oct 2, 1996, A1.
13. Office of the Special Assistant for Gulf War Illnesses: Case Narrative: US Demolition Operations at the Khamisiyah ammunition storage point. 4-14-1997. http://www.gulflink.osd.mil/khamisiyah-ii/index.html.
14. Winkenwerder W: US demolition operations at Khamisiyah. Final report. 2002. http://www.gulflink.osd.mil/khamisiyah-iii/.
15. Iannacchione VG, Dever JA, Bann CM, Considine KA, Creel D, Carson CP, Best H, Haley RW: Validation of a research case definition of Gulf War illness in the 1991 US military population. Neuroepidemiology 2011; 37: 129-140.
16. Haley RW, Kurt TL, Hom J: Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 1997; 277: 215-222.
17. Haley RW, Luk GD, Petty F: Use of structural equation modeling to test the construct validity of a case definition of Gulf War syndrome: invariance over developmental and validation samples, service branches and publicity. Psychiatry Res 2001; 102: 175-200.
18. Fukuda K, Nisenbaum R, Stewart G, Thompson WW, Robin L, Washko RM, Noah DL, Barrett DH, Randall B, Herwaldt BL, Mawle AC, Reeves WC: Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 1998; 280: 981-988.
19. Donta ST, Clauw DJ, Engel CC Jr, Guarino P, Peduzzi P, Williams DA, Skinner JS, Barkhuizen A, Taylor T, Kazis LE, Sogg S, Hunt SC, Dougherty CM, Richardson RD, Kunkel C, Rodriguez W, Alicea E, Chiliade P, Ryan M, Gray GC, Lutwick L, Norwood D, Smith S, Everson M, Blackburn W, Martin W, Griffiss JM, Cooper R, Renner E, Schmitt J, McMurtry C, Thakore M, Mori D, Kerns R, Park M, Pullman-Mooar S, Bernstein J, Hershberger P, Salisbury DC, Feussner JR, VA Cooperative Study No. 470 Study Group: Cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illnesses: a randomized controlled trial. JAMA 2003; 289: 1396-1404.
20. Donta ST, Engel CC Jr, Collins JF, Baseman JB, Dever LL, Taylor T, Boardman KD, Kazis LE, Martin SE, Horney RA, Wiseman AL, Kernodle DS, Smith RP, Baltch AL, Handanos C, Catto B, Montalvo L, Everson M, Blackburn W, Thakore M, Brown ST, Lutwick L, Norwood D, Bernstein J, Bacheller C, Ribner B, Church LW, Wilson KH, Guduru P, Cooper R, Lentino J, Hamill RJ, Gorin AB, Gordan V, Wagner D, Robinson C, DeJace P, Greenfield R, Beck L, Bittner M, Schumacher HR, Silverblatt F, Schmitt J, Wong E, Ryan MA, Figueroa J, Nice C, Feussner JR; VA Cooperative Study No. 475 Study Group: Benefits and harms of doxycycline treatment for Gulf War veterans' illnesses: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2004; 141: 85-94.
21. SUDAAN Language Manual, Release 10.0. Research Triangle Park, Research Triangle Institute, 2008.
22. Keane TM, Fairbank JA, Caddell JM, Zimering RT, Taylor K, Mora C: Clinical evaluation of a measure to assess combat exposure. Psychol Assess 1989; 1: 53-55.
23. Rothman KJ, Greenland S, Lash TL: Modern Epidemiology. Philadelphia, Lippincott Williams & Wilkins, 2008, pp 316-317.
24. Bullman TA, Mahan CM, Kang HK, Page WF: Mortality in US Army Gulf War veterans exposed to 1991 Khamisiyah chemical munitions destruction. Am J Publ Health 2005; 95: 1382-1388.
25. Barth SK, Kang HK, Bullman TA, Wallin MT: Neurological mortality among US veterans of the Persian Gulf War: 13-year follow-up. Am J Ind Med 2009; 52: 663-670.
26. Haley RW, Kurt TL: Self-reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiologic study. JAMA 1997; 277: 231-237.
27. Wessely S, Unwin C, Hotopf M, Hull L, Ismail K, Nicolaou V: Stability of recall of military hazards over time: evidence from the Persian Gulf War of 1991. Br J Psychiatry 2003; 183: 314-322.
28. Li WF, Costa LG, Furlong CE: Serum paraoxonase status: a major factor in determining resistance to organophosphates. J Toxicol Environ Health 1993; 40: 337-346.
29. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE: The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 1996; 14: 334-336.
30. Valiyaveettil M, Alamneh Y, Rezk P, Perkins MW, Sciuto AM, Doctor BP, Nambiar MP: Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs. Toxicol Lett 2011; 202: 203-208.
31. Haley RW, Billecke S, La Du BN: Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol 1999; 157: 227-233.
32. Furlong CE: PON1 status and neurologic symptom complexes in Gulf War veterans. Genome Res 2000; 10: 153-155.
33. Haley RW, Maddrey AM, Gershenfeld HK: Severely reduced functional status in veterans fitting a case definition of Gulf War syndrome. Am J Publ Health 2002; 92: 46-47.
34. Gray GC, Smith TC, Knoke JD, Heller JM: The postwar hospitalization experience of Gulf War Veterans possibly exposed to chemical munitions destruction at Khamisiyah, Iraq. Am J Epidemiol 1999; 150: 532-540.
35. Kang HK, Bullman TA: Mortality among US veterans of the Persian Gulf War: 7-year follow-up. Am J Epidemiol 2001; 154: 399-405.
36. Smith TC, Smith B, Ryan MA, Gray GC, Hooper TI, Heller JM, Dalager NA, Kang HK, Gackstetter GD: Ten years and 100,000 participants later: occupational and other factors influencing participation in US Gulf War health registries. J Occup Environ Med 2002; 44: 758-768.
37. Smith TC, Gray GC, Weir JC, Heller JM, Ryan MA: Gulf War veterans and Iraqi nerve agents at Khamisiyah: postwar hospitalization data revisited. Am J Epidemiol 2003; 158: 457-467.
38. Smith TC, Jimenez DL, Smith B, Gray GC, Hooper TI, Gackstetter GD, Heller JM, Dalager NA, Kang HK, Hyams KC, Ryan MA: The postwar hospitalization experience of Gulf War veterans participating in US health registries. J Occup Environ Med 2004; 46: 386-397.
39. Davis LE, Eisen SA, Murphy FM, Alpern R, Parks BJ, Blanchard M, Reda DJ, King MK, Mithen FA, Kang HK: Clinical and laboratory assessment of distal peripheral nerves in Gulf War veterans and spouses. Neurology 2004; 63: 1070-1077.
40. Mahan CM, Page WF, Bullman TA, Kang HK: Health effects in Army Gulf War veterans possibly exposed to chemical munitions destruction at Khamisiyah, Iraq: Part I. Morbidity associated with potential exposure. Mil Med 2005; 170: 935-944.
41. Page WF, Mahan CM, Kang HK, Bullman TA: Health effects in Army Gulf War veterans possibly exposed to chemical munitions destruction at Khamisiyah, Iraq: Part II. Morbidity associated with notification of potential exposure. Mil Med 2005; 170: 945-951.
42. Blanchard MS, Eisen SA, Alpern R, Karlinsky J, Toomey R, Reda DJ, Murphy FM, Jackson LW, Kang HK: Chronic multisymptom illness complex in Gulf War I veterans 10 years later. Am J Epidemiol 2006; 163: 66-75.
43. Gackstetter GD, Hooper TI, DeBakey SF, Johnson A, Nagaraj BE, Heller JM, Kang HK: Fatal motor vehicle crashes among veterans of the 1991 Gulf War and exposure to munitions demolitions at Khamisiyah: a nested case-control study. Am J Ind Med 2006; 49: 261-270.
44. Proctor SP, Heaton KJ, Heeren T, White RF: Effects of sarin and cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US army veterans. Neurotoxicology 2006; 27: 931-939.
45. Heaton KJ, Palumbo CL, Proctor SP, Killiany RJ, Yurgelun-Todd DA, White RF: Quantitative magnetic resonance brain imaging in US army veterans of the 1991 Gulf War potentially exposed to sarin and cyclosarin. Neurotoxicology 2007; 28: 761-769.
46. Miranda ML, Alicia Overstreet GM, Tassone E, Allen KD, Horner RD: Spatial analysis of the etiology of amyotrophic lateral sclerosis among 1991 Gulf War veterans. Neurotoxicology 2008; 29: 964-970.
47. Toomey R, Alpern R, Vasterling JJ, Baker DG, Reda DJ, Lyons MJ, Henderson WG, Kang HK, Eisen SA, Murphy FM: Neuropsychological functioning of U.S. Gulf War veterans 10 years after the war. J Int Neuropsychol Soc 2009; 15: 717-729.
48. Chao LL, Rothlind JC, Cardenas VA, Meyerhoff DJ, Weiner MW: Effects of low-level exposure to sarin and cyclosarin during the 1991 Gulf War on brain function and brain structure in US veterans. Neurotoxicology 2010; 31: 493-501.